Augmented Reality Advantage SentiAR offers real time holographic AR visualization for interventional cardiac procedures, suggesting strong sales potential with hospitals and surgical centers seeking precision, reduced radiation exposure, and improved outcomes in electrophysiology and ablation.

Funding and Growth With a total funding of around 24 million and recent Series B financing, SentiAR demonstrates growth momentum and investor validation, indicating readiness to scale deployments, support more customer sites, and invest in training and integration services.

University Heritage Spun out from Washington University and licensed from the Silva lab, the company combines academic credibility with practical clinical workflow integration, appealing to large academic medical centers and teaching hospitals prioritizing proven technology transfer and collaboration.

Target Market Signals The core focus on interventional procedures and cardiac ablation positions SentiAR to target cardiology programs, surgical centers, and hospitals expanding minimally invasive therapies where visualization and precision can drive adoption and better patient safety metrics.

Competitive Position As a specialized AR visualization platform with enterprise software roots and a history of design awards, SentiAR can differentiate from generic VR trainers by offering real patient anatomy visualization, potential collaborations with device manufacturers, and integration with existing medical imaging ecosystems.